Latest News for: dravet syndrome

Edit

Stoke Therapeutics and Biogen Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet Syndrome (Form 8-K) (Stoke Therapeutics Inc)

Public Technologies 11 Aug 2025
Stoke Therapeutics and Biogen Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet Syndrome ... - Dravet syndrome ... About Dravet Syndrome.
Edit

Dravet Syndrome Pipeline Experiences Rapid Expansion as Over 10+ Leading Companies Advance Novel Therapies

GetNews 25 Jul 2025
... Dravet Syndrome- Unmet Needs Dravet Syndrome- Market Drivers and Barriers Dravet Syndrome- Future Perspectives and Conclusion Dravet Syndrome Analyst Views Dravet Syndrome Key Companies Appendix.
Edit

Dravet Syndrome Treatment Market 2034: EMA, PDMA, FDA Approvals, Medication, NICE Approvals, Clinical Trials, Revenue, ...

MENA FN 26 May 2025
(MENAFN - GetNews) "Dravet Syndrome Treatment Market"Dravet Syndrome Companies are Takeda, Eisai, Stoke Therapeurtics, EpyGenix Therapeutics, Marinus Pharmaceuticals, Stoke Therapeutics, Inc, ... .
  • 1

Article Search

tools
×
×
×
×